Details for Patent: 8,479,730

Which drugs does patent 8,479,730 protect, and when does it expire?

Patent 8,479,730 protects ARCAPTA NEOHALER, SEEBRI, and UTIBRON, and is included in three NDAs.

This patent has thirty-seven patent family members in thirty-one countries.

Summary for Patent: 8,479,730

Title:	Inhaler device
Abstract:	An inhaler device (1) for powdered medicaments. The device (1) has a body (5) that has a recess (50) for holding a capsule containing a powdered medicament to be inhaled, at least one air passage (90) that is tangentially disposed to the recess (50) , and a mouthpiece (30) that includes a coaxially disposed inhalation passage (70) that communicates with the recess (50) of the body (5). The body (5) has a pair of opposed spring (105) biased push-buttons (40) that each include at least one piercing element (95) for piercing the capsule when loaded in the recess (50). The medicament is released from the pierced capsule when air is drawn through the air passage(s) (90) into the recess (50) and swirled about therein. The mouthpiece (30) is pivotally attached to the edge of the body (5) so that it is pivotable between an open loading position and a closed dispensing position about an axis that is perpendicular to the longitudinal axis of the inhaler (1).
Inventor(s):	Ziegler; Dominik (Basel, CH), Smetham; Grant (Cambridge, GB), Citterio; Mauro (Osnago, IT)
Assignee:	Novartis AG (Basil, CH)
Application Number:	11/568,466
Patent Claim Types: see list of patent claims	Dosage form; Delivery; Device; Compound;

Drugs Protected by US Patent 8,479,730

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novartis	ARCAPTA NEOHALER	indacaterol maleate	POWDER;INHALATION	022383-001	Jul 1, 2011		DISCN	Yes	No			Y
Novartis	SEEBRI	glycopyrrolate	POWDER;INHALATION	207923-001	Oct 29, 2015		DISCN	Yes	No			Y
Novartis	UTIBRON	glycopyrrolate; indacaterol maleate	POWDER;INHALATION	207930-001	Oct 29, 2015		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 8,479,730

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0410712.4	May 13, 2004

PCT Information
PCT Filed	May 12, 2005	PCT Application Number:	PCT/EP2005/005182
PCT Publication Date:	December 01, 2005	PCT Publication Number:	WO2005/113042

International Family Members for US Patent 8,479,730

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	051353
Austria	502666
Australia	2005245095
Brazil	PI0511073